-
公开(公告)号:US20230057383A1
公开(公告)日:2023-02-23
申请号:US17799901
申请日:2020-03-21
申请人: Mihan JAFARI JAVID
发明人: Mihan Jafari Javid , Amir Dadgari
摘要: The present invention is directed to compositions and methods for the prevention and treatment of pathological vascular occlusive disorders and related medical conditions. The composition comprising boric acid, sodium chloride, potassium chloride, aluminum sulfate and chamomile.
-
2.
公开(公告)号:US11351148B1
公开(公告)日:2022-06-07
申请号:US17563944
申请日:2021-12-28
申请人: Matthias W Rath
IPC分类号: A61K31/07 , A61K31/51 , A61K33/00 , A61K33/06 , A61K33/30 , A61K36/54 , A61K36/87 , A61K31/375 , A61K31/714 , A61K31/355 , A61K31/593 , A61K31/197 , A61K31/455 , A61K36/282 , A61K31/385 , A61K31/7004 , A61K31/4415 , A61K31/519 , A61K36/82 , A61K31/122 , A61K33/18 , A61K33/32 , A61K31/525 , A61K33/22 , A61K36/61 , A61K31/047 , A61K31/4188 , A61K31/198 , A61K31/575 , A61K36/185 , A61K31/7084
摘要: A threefold decrease in α-amylase inhibition, increase in insulin secretion and glucose uptake increase by the pharmaceutical composition of several naturally occurring substances and vitamins were observed when compared to the control cells, and a c.a. 1-1.5 fold decrease when compared to the positive control. More specifically Mix A shows significant effect on increased insulin secretion and glucose uptake by cells.
-
公开(公告)号:US20220008458A1
公开(公告)日:2022-01-13
申请号:US17365695
申请日:2021-07-01
IPC分类号: A61K33/30 , A61K33/34 , A61K33/04 , A61K33/32 , A61K33/06 , A61K33/00 , A61K33/22 , A61K47/10 , A61K33/24 , A61K47/20 , A61K31/7004 , A61K9/00 , A61P3/02
摘要: Injectable compositions that can be added to parenteral nutrition are provided. In particular, a stable injectable composition is provided which includes water, and at least one of about 800 μg to about 4,000 μg of zinc, about 40 μg to about 400 μg of copper, from about 4 μg to about 90 μg of selenium, or from about 1 μg to about 80 μg of manganese per 1 mL of the injectable composition. Methods of preparing and using of the stable injectable composition are also provided.
-
公开(公告)号:US20210220422A1
公开(公告)日:2021-07-22
申请号:US16747312
申请日:2020-01-20
申请人: Jonathan Parker
发明人: Jonathan Parker
IPC分类号: A61K36/81 , A61K36/41 , A61K36/79 , A61K36/28 , A61K36/258 , A61K35/02 , A61K36/25 , A61K36/9068 , A61K36/484 , A61K36/67 , A61K31/455 , A61K33/00 , A61K31/375 , A61K31/593 , A61K33/06 , A61K36/48 , A61K36/185 , A61K31/404 , A61K33/22 , A61K33/30 , A61K33/24 , A61K33/18 , A61K33/04 , A61K36/53 , A61K31/714 , A61K36/73 , A23L33/105 , A23L33/155 , A23L33/16
摘要: Described are natural herbal supplement compositions that provide a sense of energy, stress relief, well-being, and vitality in humans and most mammals. In one aspect, the compositions include a unique combination of ingredients categorized into one of three groups, Adaptogens, Bioenhancers, and Circulation Enhancers, and selecting several plants from each group to create a base formula. The base formula is then combined with other supportive nutrients to form a nutrient supplement.
-
公开(公告)号:US20200268775A1
公开(公告)日:2020-08-27
申请号:US16870868
申请日:2020-05-08
IPC分类号: A61K31/702 , A61K31/661 , A61K9/00 , A23D9/013 , A61K38/28 , A61K38/44 , A61K45/06 , A61K47/12 , A61K47/24 , A61K47/26 , A61K31/05 , A61K31/122 , A61K31/16 , A61K31/375 , A61K31/385 , A61K31/522 , A61K31/593 , A61K31/66 , A61K31/683 , A61K31/685 , A61K31/7028 , A61K31/716 , A61K31/733 , A61K33/22 , A23L29/10 , A23L29/244 , A23L33/105 , A23L33/115 , A23L33/12 , A61P39/06 , A61P21/00
摘要: A method of oral delivery of phospholipid/inulin compositions comprising capsules, tablets, chewable wafers or powdered material in a liquid carrier in quantities effective for treating pain from overactive neurons. The phospholipid/inulin compositions were also shown to be effective in reducing depression and intestinal malfunctions including, but not limited to, diarrhea and constipation, and improving sleep pattern. The compositions further including effective amounts of caffeine also reduces fatigue and enhances alertness and focus.
-
公开(公告)号:US20200261527A1
公开(公告)日:2020-08-20
申请号:US16858352
申请日:2020-04-24
申请人: Shui Yin Lo
发明人: Shui Yin Lo
IPC分类号: A61K36/481 , A61K35/32 , A61K33/42 , A61K31/203 , A61K36/18 , A61K36/232 , A61K31/59 , A61K31/51 , A61K31/4418 , A61K33/22 , A61K35/64 , A61K33/30 , A61K35/644 , A61K35/586 , A61K33/06
摘要: A hybrid herbal and drug composition includes an amount of Chinese herb about 0.01 to 5% by weight of the composition; an amount of animal-based matter about 0.01 to 5% by weight of the composition; an amount of vitamin about 0.01 to 5% by weight of the composition; an amount of mineral about 0.01 to 5% by weight of the composition; an amount of hormone about 0.01 to 5% by weight of the composition; an amount of factory produced product about 0.01 to 5% by weight of the composition; and an amount of the purified water about 70% to 99.94% by weight of the composition.
-
公开(公告)号:US10471096B2
公开(公告)日:2019-11-12
申请号:US15540830
申请日:2016-01-05
申请人: Osamu Yamada , OSU CORPORATION
发明人: Osamu Yamada , Junpei Maruo
IPC分类号: A61K33/24 , A23L2/52 , A61K8/29 , A61Q11/00 , A61Q19/00 , A61K33/00 , A61K33/22 , A61K33/26 , A61K33/34 , A61K33/38 , A23L33/16 , A61K8/11 , A61K8/19 , A61K8/25 , A61K33/44
摘要: Disclosed are a pharmaceutical composition, cosmetic product, and food or drink product each comprising a porous ceramic obtained by combustion synthesis of a starting material comprising (1) titanium and (2) at least one member selected from the group consisting of carbon, boron, nitrogen, and silicon; a pharmaceutical composition and cosmetic product each comprising a radical- and nanobubble-containing liquid; and a blood treatment device comprising a blood flow channel for extracorporeal circulation of a patient's blood, the blood flow channel being provided with the porous ceramic above, and the porous ceramic and the blood are brought into contact with each other.
-
公开(公告)号:US10258567B1
公开(公告)日:2019-04-16
申请号:US15815837
申请日:2017-11-17
发明人: Allison Krebs-Bensch
IPC分类号: A61K9/48 , A61K9/00 , A61K35/747 , A61K31/355 , A61K31/341 , A61K47/36 , A61K33/22
摘要: A formulation for vaginal administration comprising an effective amount of a composition of dried Lactobacillus cells and boric acid, with a carrier. The composition can include one or more antioxidants. Optionally, the composition is in a unit dosage form. Also provided are methods for making and using the composition.
-
公开(公告)号:US20190091242A1
公开(公告)日:2019-03-28
申请号:US15719127
申请日:2017-09-28
申请人: Natals, Inc.
发明人: Luke BUCCI , Katerina SCHNEIDER
IPC分类号: A61K31/593 , A61K31/355 , A61K36/31 , A61K31/122 , A61K31/519 , A61K31/714 , A61K33/26 , A61K33/06 , A61K33/22 , A61K31/202 , A61K36/02 , A61K9/16 , A61K9/48 , A23L33/00 , A23L33/12 , A23L33/155 , A23L33/15 , A23L33/16 , B65D25/54 , B65D81/20
摘要: Provided herein are dietary supplement compositions comprising a plurality of beadlets and an oil. Provided herein are also dietary supplement compositions comprising a plurality of mini-tabs and oil. The beadlets or mini-tabs comprise at least one nutrient that is miscible in aqueous solution, and the oil comprises at least one fat-soluble nutrient. The composition may be contained within one or more capsules, and be packaged with a scented insert.
-
公开(公告)号:US20190062274A1
公开(公告)日:2019-02-28
申请号:US16175144
申请日:2018-10-30
发明人: Yasutomi ASANO , Takuto KOJIMA , Osamu KURASAWA , Tzu-Tshin WONG , Yasuhiro HIRATA , Naoki IWAMURA , Bunnai SAITO , Yuta TANAKA , Ryosuke ARAI , Shinichi IMAMURA , Kazuko YONEMORI , Yasufumi MIYAMOTO , Shuji KITAMURA , Osamu SANO
IPC分类号: C07D211/58 , C07F9/6509 , C07D405/06 , A61P3/00 , A61P35/00 , C07B59/00 , C07D413/14 , C07F5/02 , C07D519/00 , C07D513/04 , C07D498/04 , C07D487/04 , C07D471/04 , C07D417/14 , C07D417/12 , C07D417/06 , C07D413/06 , C07D409/12 , C07D401/12 , C07D401/06 , C07D215/42 , A61K33/22 , A61K31/661 , A61K31/5355 , A61K31/517 , A61K31/506 , A61K31/498 , A61K31/4709 , A61K31/452 , A61K31/451 , A61K31/4468 , A61K31/444 , A61K31/4439 , A61K31/4436 , A61K31/4433 , A61K31/443 , A61K31/437 , C07D401/14
CPC分类号: C07D211/58 , A61K31/437 , A61K31/443 , A61K31/4433 , A61K31/4436 , A61K31/4439 , A61K31/444 , A61K31/4468 , A61K31/451 , A61K31/452 , A61K31/4709 , A61K31/498 , A61K31/506 , A61K31/517 , A61K31/5355 , A61K31/661 , A61K33/22 , A61P3/00 , A61P35/00 , C07B59/002 , C07B2200/05 , C07D215/42 , C07D401/06 , C07D401/12 , C07D401/14 , C07D405/06 , C07D409/12 , C07D413/06 , C07D413/14 , C07D417/06 , C07D417/12 , C07D417/14 , C07D471/04 , C07D487/04 , C07D498/04 , C07D513/04 , C07D519/00 , C07F5/02 , C07F9/6509 , Y02P20/55
摘要: The present invention relates to a compound which can be useful for the treatment or prevention of SPT-related diseases including cancer and congenital diseases associated with sphingolipid accumulation (including Niemann-Pick disease).
-
-
-
-
-
-
-
-
-